| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.858 | 0.004 | 0.858 | Antiadrenergic | 0.674 0.004 CID_154699818 | ||
| 0.858 | 0.004 | 0.858 | Adrenaline antagonist | 0.674 0.004 CID_154699818 | ||
| 0.693 | 0.003 | 0.693 | Fibroblast growth factor 1 antagonist | 0.635 0.004 CID_154699818 | ||
| 0.544 | 0.003 | 0.544 | Alpha adrenoreceptor agonist | 0.112 0.024 CID_154699818 | ||
| 0.52 | 0.001 | 0.52 | Alpha 1b adrenoreceptor agonist | 0.421 0.001 CID_154699818 | ||
| 0.466 | 0.004 | 0.466 | Alpha 2b adrenoreceptor antagonist | 0.096 0.079 CID_154699818 | ||
| 0.464 | 0.004 | 0.464 | Nav1.1 sodium channel blocker | 0.307 0.008 CID_154699818 | ||
| 0.451 | 0.001 | 0.451 | Alpha 1a adrenoreceptor agonist | 0.296 0.001 CID_154699818 | ||
| 0.441 | 0.004 | 0.441 | Alpha 2a adrenoreceptor antagonist | 0.079 0.049 CID_154699818 | ||
| 0.453 | 0.03 | 0.453 | Spasmolytic | 0.36 0.05 CID_154699818 | ||
| 0.424 | 0.004 | 0.424 | Alpha 1 adrenoreceptor agonist | 0.072 0.026 CID_154699818 | ||
| 0.415 | 0.006 | 0.44 | Nav1.2 sodium channel blocker | 0.44 0.005 CID_154699818 | CID_154699818 | |
| 0.404 | 0.005 | 0.404 | Alpha 2 adrenoreceptor antagonist | 0.077 0.071 CID_154699818 | ||
| 0.39 | 0.003 | 0.39 | Alpha 2 adrenoreceptor agonist | 0.102 0.014 CID_154699818 | ||
| 0.425 | 0.046 | 0.631 | Angiogenesis inhibitor | 0.631 0.014 CID_154699818 | CID_154699818 | |
| 0.388 | 0.013 | 0.388 | Vascular endothelial growth factor 2 antagonist | 0.101 0.071 CID_154699818 | ||
| 0.379 | 0.015 | 0.379 | Vascular endothelial growth factor antagonist | 0.141 0.058 CID_154699818 | ||
| 0.366 | 0.005 | 0.366 | Alpha 2c adrenoreceptor antagonist | 0.098 0.068 CID_154699818 | ||
| 0.369 | 0.02 | 0.369 | Growth factor antagonist | 0.191 0.049 CID_154699818 | ||
| 0.35 | 0.002 | 0.35 | Fibroblast growth factor 4 antagonist | 0.276 0.003 CID_154699818 | ||
| 0.319 | 0.004 | 0.319 | CXC chemokine receptor antagonist | 0.201 0.005 CID_154699818 | ||
| 0.315 | 0.004 | 0.315 | Adrenaline agonist | 0.111 0.03 CID_154699818 | ||
| 0.388 | 0.089 | 0.388 | Calcium channel L-type activator | |||
| 0.292 | 0.002 | 0.292 | Alpha 2d adrenoreceptor antagonist | 0.233 0.002 CID_154699818 | ||
| 0.357 | 0.082 | 0.357 | GABA C receptor rho-3 antagonist | |||
| 0.279 | 0.007 | 0.279 | Nav1.6 sodium channel blocker | |||
| 0.268 | 0.001 | 0.268 | Alpha 1L adrenoreceptor agonist | 0.221 0.001 CID_154699818 | ||
| 0.281 | 0.017 | 0.281 | Alpha adrenoreceptor antagonist | 0.111 0.051 CID_154699818 | ||
| 0.256 | 0.013 | 0.256 | Nav1.3 sodium channel blocker | |||
| 0.245 | 0.007 | 0.245 | CXC chemokine 4 receptor antagonist | 0.092 0.027 CID_154699818 | ||
| 0.243 | 0.012 | 0.243 | Chemokine receptor antagonist | |||
| 0.305 | 0.087 | 0.305 | Calcium channel activator | |||
| 0.223 | 0.026 | 0.223 | Insulin secretagoues | |||
| 0.205 | 0.014 | 0.205 | Alpha 1b adrenoreceptor antagonist | |||
| 0.285 | 0.105 | 0.285 | Vasodilator, peripheral | |||
| 0.214 | 0.036 | 0.214 | Acetylcholine M1 receptor antagonist | |||
| 0.198 | 0.021 | 0.198 | Alpha 1 adrenoreceptor antagonist | |||
| 0.178 | 0.002 | 0.178 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 CID_154699818 | ||
| 0.243 | 0.075 | 0.243 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.247 | 0.083 | 0.247 | Aldehyde oxidase inhibitor | |||
| 0.153 | 0.002 | 0.153 | Alpha 1d adrenoreceptor agonist | 0.065 0.009 CID_154699818 | ||
| 0.151 | 0.005 | 0.151 | Beta 3 adrenoreceptor antagonist | 0.065 0.043 CID_154699818 | ||
| 0.182 | 0.037 | 0.182 | Anesthetic local | |||
| 0.156 | 0.014 | 0.156 | Alpha 1d adrenoreceptor antagonist | |||
| 0.323 | 0.183 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.301 | 0.164 | 0.301 | 5 Hydroxytryptamine release inhibitor | |||
| 0.149 | 0.024 | 0.149 | Alpha 1a adrenoreceptor antagonist | |||
| 0.224 | 0.1 | 0.224 | Cardiotonic | |||
| 0.205 | 0.081 | 0.205 | Nitric-oxide synthase stimulant | |||
| 0.124 | 0.006 | 0.124 | Beta 2 adrenoreceptor antagonist | |||
| 0.12 | 0.01 | 0.12 | Beta adrenoreceptor antagonist | |||
| 0.108 | 0.003 | 0.108 | Parathyroid hormone antagonist | 0.088 0.004 CID_154699818 | ||
| 0.11 | 0.008 | 0.11 | Beta 1 adrenoreceptor antagonist | |||
| 0.158 | 0.057 | 0.158 | MAO inhibitor | |||
| 0.102 | 0.005 | 0.102 | Kallikrein 7 inhibitor | 0.083 0.011 CID_154699818 | ||
| 0.292 | 0.202 | 0.292 | Caspase 9 stimulant | |||
| 0.137 | 0.052 | 0.137 | Acetylcholine muscarinic antagonist | |||
| 0.158 | 0.074 | 0.158 | Peroxidase inhibitor | |||
| 0.102 | 0.022 | 0.102 | Viral attachment inhibitor | 0.083 0.043 CID_154699818 | ||
| 0.138 | 0.06 | 0.138 | Cholinergic antagonist | |||
| 0.134 | 0.059 | 0.134 | Acetylcholine antagonist | |||
| 0.078 | 0.003 | 0.078 | Alpha 2d adrenoreceptor agonist | 0.048 0.005 CID_154699818 | ||
| 0.114 | 0.04 | 0.114 | Estrogen receptor beta antagonist | |||
| 0.121 | 0.05 | 0.121 | MAO B inhibitor | |||
| 0.095 | 0.028 | 0.095 | CC chemokine 5 receptor agonist | 0.084 0.052 CID_154699818 | ||
| 0.09 | 0.025 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.12 | 0.056 | 0.12 | Estrogen antagonist | |||
| 0.104 | 0.043 | 0.104 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.06 | 0.003 | 0.06 | Imidazoline I1 receptor antagonist | |||
| 0.091 | 0.039 | 0.091 | Estrogen-related receptor beta agonist | |||
| 0.15 | 0.102 | 0.15 | ATPase inhibitor | |||
| 0.188 | 0.144 | 0.188 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.101 | 0.059 | 0.101 | Creatine kinase inhibitor | |||
| 0.138 | 0.099 | 0.138 | CF transmembrane conductance regulator agonist | |||
| 0.18 | 0.142 | 0.209 | Superoxide dismutase inhibitor | 0.209 0.108 CID_154699818 | CID_154699818 | |
| 0.042 | 0.004 | 0.042 | Alpha 2b adrenoreceptor agonist | |||
| 0.108 | 0.074 | 0.108 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.052 | 0.019 | 0.052 | NMDA receptor subunit 3A antagonist | |||
| 0.111 | 0.078 | 0.111 | Transcription factor STAT6 inhibitor | |||
| 0.148 | 0.116 | 0.148 | Anesthetic general | |||
| 0.174 | 0.142 | 0.174 | Hypoglycemic | |||
| 0.046 | 0.015 | 0.046 | Prostacyclin antagonist | |||
| 0.118 | 0.087 | 0.118 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.035 | 0.004 | 0.035 | Alpha 2c adrenoreceptor agonist | |||
| 0.053 | 0.023 | 0.053 | NMDA receptor subunit 3B antagonist | |||
| 0.145 | 0.116 | 0.147 | Phospholipase C inhibitor | 0.147 0.113 CID_154699818 | CID_154699818 | |
| 0.058 | 0.029 | 0.058 | Histamine agonist | |||
| 0.055 | 0.026 | 0.055 | 5 Hydroxytryptamine 1A agonist | |||
| 0.067 | 0.04 | 0.067 | 5 Hydroxytryptamine 2A agonist | |||
| 0.028 | 0.003 | 0.028 | Imidazoline I2 receptor antagonist | |||
| 0.084 | 0.062 | 0.084 | Histamine N-methyltransferase inhibitor | |||
| 0.154 | 0.135 | 0.154 | MAP kinase kinase 5 inhibitor | |||
| 0.095 | 0.079 | 0.095 | Beta glucuronidase inhibitor | |||
| 0.094 | 0.078 | 0.094 | Ferrochelatase inhibitor | |||
| 0.06 | 0.044 | 0.06 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.08 | 0.065 | 0.08 | NMDA receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Estrogen-related receptor beta antagonist | |||
| 0.071 | 0.059 | 0.071 | Analgesic, opioid | |||
| 0.067 | 0.056 | 0.067 | Telomerase inhibitor | |||
| 0.08 | 0.069 | 0.08 | D-Ala-D-Ala ligase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.074 | 0.068 | 0.122 | Glycine receptor antagonist | 0.122 0.017 CID_154699818 | CID_154699818 | |
| 0.032 | 0.027 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.045 | 0.042 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.157 | 0.157 | 0.2 | Antioxidant | 0.2 0.113 CID_154699818 | CID_154699818 | |
| 0.096 | 0.097 | 0.141 | Acetylcholine release stimulant | 0.141 0.023 CID_154699818 | CID_154699818 | |
| 0.057 | 0.066 | 0.077 | NMDA 2 receptor antagonist | 0.077 0.046 CID_154699818 | CID_154699818 | |
| 0.042 | 0.062 | 0.237 | NMDA 2B receptor antagonist | 0.237 0.005 CID_154699818 | CID_154699818 | |
| 0.066 | 0.092 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.061 CID_154699818 | CID_154699818 | |
| 0.045 | 0.081 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_154699818 | CID_154699818 | |
| 0.151 | 0.197 | 0.193 | RNA-directed DNA polymerase inhibitor | 0.193 0.11 CID_154699818 | CID_154699818 | |
| 0.013 | 0.099 | 0.068 | NMDA 2D receptor antagonist | 0.068 0.005 CID_154699818 | CID_154699818 | |
| 0.014 | 0.102 | 0.049 | Estrogen agonist | 0.049 0.036 CID_154699818 | CID_154699818 | |
| 0.054 | 0.154 | 0.095 | Gastric antisecretory | 0.095 0.072 CID_154699818 | CID_154699818 | |
| 0.025 | 0.13 | 0.054 | H+/K+-transporting ATPase inhibitor | 0.054 0.031 CID_154699818 | CID_154699818 | |
| 0.055 | 0.16 | 0.146 | Triose-phosphate isomerase inhibitor | 0.146 0.021 CID_154699818 | CID_154699818 | |
| 0.017 | 0.134 | 0.046 | Purinergic P2Y2 antagonist | 0.046 0.012 CID_154699818 | CID_154699818 | |
| 0.024 | 0.176 | 0.101 | HIV-1 integrase (3'-Processing) inhibitor | 0.101 0.026 CID_154699818 | CID_154699818 | |
| 0.009 | 0.184 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_154699818 | CID_154699818 | |
| 0.023 | 0.2 | 0.067 | Carbonic anhydrase VA inhibitor | 0.067 0.049 CID_154699818 | CID_154699818 | |
| 0.019 | 0.208 | 0.084 | Carbonic anhydrase V inhibitor | 0.084 0.034 CID_154699818 | CID_154699818 | |
| 0.014 | 0.222 | 0.077 | HIV-1 integrase (Strand Transfer) inhibitor | 0.077 0.032 CID_154699818 | CID_154699818 | |
| 0.025 | 0.255 | 0.091 | CDC25A inhibitor | 0.091 0.034 CID_154699818 | CID_154699818 | |
| 0.014 | 0.259 | 0.613 | Cholecystokinin B agonist | 0.613 0.002 CID_154699818 | CID_154699818 | |
| 0.023 | 0.271 | 0.091 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 CID_154699818 | CID_154699818 | |
| 0.004 | 0.286 | 0.236 | Cholecystokinin B antagonist | 0.236 0.004 CID_154699818 | CID_154699818 | |
| 0.046 | 0.332 | 0.221 | Diuretic | 0.221 0.037 CID_154699818 | CID_154699818 | |
| 0.012 | 0.305 | 0.098 | Selectin antagonist | 0.098 0.028 CID_154699818 | CID_154699818 | |
| 0.005 | 0.307 | 0.265 | Cholecystokinin antagonist | 0.265 0.004 CID_154699818 | CID_154699818 | |
| 0.004 | 0.319 | 0.51 | Cholecystokinin A agonist | 0.51 0.002 CID_154699818 | CID_154699818 | |
| 0.03 | 0.361 | 0.187 | Protein-tyrosine phosphatase inhibitor | 0.187 0.052 CID_154699818 | CID_154699818 | |
| 0.04 | 0.372 | 0.203 | Dual specificity phosphatase inhibitor | 0.203 0.053 CID_154699818 | CID_154699818 | |
| 0.004 | 0.346 | 0.619 | Cholecystokinin agonist | 0.619 0.002 CID_154699818 | CID_154699818 | |
| 0.037 | 0.384 | 0.212 | Dual specificity phosphatase 3 inhibitor | 0.212 0.055 CID_154699818 | CID_154699818 | |
| 0.003 | 0.354 | 0.061 | Estrone sulfatase inhibitor | 0.061 0.006 CID_154699818 | CID_154699818 | |
| 0.015 | 0.405 | 0.084 | Thrombin inhibitor | 0.084 0.038 CID_154699818 | CID_154699818 | |
| 0.018 | 0.424 | 0.06 | Factor IXa inhibitor | 0.06 0.026 CID_154699818 | CID_154699818 | |
| 0.024 | 0.439 | 0.188 | Multidrug resistance-associated protein 1 inhibitor | 0.188 0.013 CID_154699818 | CID_154699818 | |
| 0.029 | 0.455 | 0.278 | Angiogenesis stimulant | 0.278 0.058 CID_154699818 | CID_154699818 | |
| 0.004 | 0.436 | 0.278 | Cholecystokinin A antagonist | 0.278 0.004 CID_154699818 | CID_154699818 | |
| 0.011 | 0.517 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.023 CID_154699818 | CID_154699818 | |
| 0.029 | 0.541 | 0.144 | Hemostatic | 0.144 0.076 CID_154699818 | CID_154699818 | |
| 0.022 | 0.685 | 0.136 | Platelet adhesion inhibitor | 0.136 0.123 CID_154699818 | CID_154699818 | |
| 0.01 | 0.691 | 0.321 | Anticoagulant | 0.321 0.025 CID_154699818 | CID_154699818 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |